Masaaki Noguchi

1.5k total citations
85 papers, 866 citations indexed

About

Masaaki Noguchi is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Masaaki Noguchi has authored 85 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 30 papers in Oncology and 29 papers in Genetics. Recurrent topics in Masaaki Noguchi's work include Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (16 papers). Masaaki Noguchi is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (16 papers). Masaaki Noguchi collaborates with scholars based in Japan and Nigeria. Masaaki Noguchi's co-authors include Norio Komatsu, Hiroyuki Mano, Yasunobu Sekiguchi, Keiji Sugimoto, Kazuo Oshimi, Koichi Sugimoto, Yasunori Ota, Kohei Miyazono, Hiroshi Suzuki and Hironori Matsuyama and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Masaaki Noguchi

75 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Noguchi Japan 14 261 245 181 180 163 85 866
Giulia Scalia Italy 16 150 0.6× 182 0.7× 129 0.7× 131 0.7× 169 1.0× 52 714
Mona Anand India 18 199 0.8× 252 1.0× 272 1.5× 209 1.2× 175 1.1× 43 908
T Motokura Japan 17 314 1.2× 287 1.2× 156 0.9× 462 2.6× 81 0.5× 20 1.0k
James Dalton United States 8 228 0.9× 550 2.2× 188 1.0× 210 1.2× 105 0.6× 14 1.3k
Maria Cantonetti Italy 20 571 2.2× 208 0.8× 306 1.7× 377 2.1× 139 0.9× 84 1.2k
Michihide Tokuhira Japan 22 394 1.5× 231 0.9× 327 1.8× 450 2.5× 220 1.3× 80 1.4k
Christian Kneitz Germany 17 216 0.8× 184 0.8× 215 1.2× 206 1.1× 585 3.6× 29 1.1k
Jean‐Philippe Jais France 5 240 0.9× 322 1.3× 103 0.6× 256 1.4× 758 4.7× 5 1.3k
Noriko Fukuhara Japan 21 530 2.0× 424 1.7× 459 2.5× 390 2.2× 304 1.9× 152 1.5k
Joon Seong Park South Korea 18 121 0.5× 365 1.5× 303 1.7× 277 1.5× 163 1.0× 96 1.0k

Countries citing papers authored by Masaaki Noguchi

Since Specialization
Citations

This map shows the geographic impact of Masaaki Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Noguchi more than expected).

Fields of papers citing papers by Masaaki Noguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Noguchi. The network helps show where Masaaki Noguchi may publish in the future.

Co-authorship network of co-authors of Masaaki Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Noguchi. A scholar is included among the top collaborators of Masaaki Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Noguchi. Masaaki Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Araki, Yoshihiko, Maki Fujishiro, Shigeki Tomita, et al.. (2023). Possible New Histological Prognostic Index for Large B-Cell Lymphoma. Journal of Clinical Medicine. 12(19). 6324–6324. 3 indexed citations
3.
Araki, Yoshihiko, Maki Fujishiro, Shigeki Tomita, et al.. (2023). Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms. Journal of Clinical and Experimental Hematopathology. 63(2). 83–89. 4 indexed citations
4.
Sekiguchi, Yasunobu, Ayumi Gomyo, Nobuo Maseki, et al.. (2023). Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 63(4). 262–265. 1 indexed citations
5.
Takahashi, Masaya, et al.. (2021). Chronic active Epstein–Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report. BMC Pregnancy and Childbirth. 21(1). 681–681. 3 indexed citations
6.
Koike, Michiaki, et al.. (2021). Two autopsy cases of pulmonary leukemic infiltration mimicking severe pneumonia in patients with acute myeloid leukemia. SHILAP Revista de lepidopterología. 16. 100269–100269. 1 indexed citations
7.
Sekiguchi, Yasunobu, Shigeki Tomita, Hiroshi Izumi, et al.. (2021). Use of Ibrutinib in 10 Patients with Treatment-Naïve or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in Real-World Clinical Practice -A Report from a Single Medical Institution.. Gan to kagaku ryōhō. 48(7). 921–926.
8.
Watanabe, Naoki, Tomoiku Takaku, Kazuyoshi Takeda, et al.. (2018). Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. International Journal of Hematology. 108(6). 588–597. 8 indexed citations
9.
Nakaseko, Chiaki, Kaichi Nishiwaki, Hitoshi Ogasawara, et al.. (2018). Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan. International Journal of Hematology. 108(2). 176–183. 4 indexed citations
11.
Sekiguchi, Yasunobu, Keiji Sugimoto, Noriko Nakamura, et al.. (2014). Acquired Factor V Inhibitor Developing after Treatment with Dabigatran Etexilate Methanesulfonate: A Case Report and Review of the Literature. Indian Journal of Hematology and Blood Transfusion. 30(S1). 275–279. 5 indexed citations
12.
Sugimoto, Keiji, Yasunobu Sekiguchi, Yasunori Ota, et al.. (2014). Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature. Journal of Clinical Oncology. 33(19). e79–e83. 5 indexed citations
13.
Edahiro, Yoko, Soji Morishita, Yumi Hironaka, et al.. (2014). JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan. International Journal of Hematology. 99(5). 625–634. 24 indexed citations
15.
Sekiguchi, Yasunobu, Keiji Sugimoto, Noriko Nakamura, et al.. (2014). Spontaneous Regression of a Clinically-Advanced Histologically Low-Grade Follicular Lymphoma Involving the Breast: Case Report and Review of the Literature. Indian Journal of Hematology and Blood Transfusion. 30(S1). 320–324. 2 indexed citations
16.
Sekiguchi, Yasunobu, et al.. (2013). CD56+ Angioimmunoblastic T-Cell Lymphoma With Evans Syndrome : A Case Report and Review of the Literature. Journal of Clinical and Experimental Hematopathology. 53(1). 37–47. 3 indexed citations
17.
Tomomatsu, Junichi, Yasushi Isobe, Kazuo Oshimi, et al.. (2010). Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutatedIGHgene, and indolent clinical behavior. Leukemia & lymphoma. 51(12). 2230–2239. 16 indexed citations
19.
Noguchi, Masaaki, Naotake Sato, Hiroki Sugimori, Kiyoshi Mori, & Kazuo Oshimi. (2001). A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells. Leukemia Research. 25(10). 847–853. 17 indexed citations
20.
Noguchi, Masaaki, et al.. (1997). T-cell Lymphoma of CD3+CD4+CD56+Granular Lymphocytes with Hemophagocytic Syndrome. Leukemia & lymphoma. 26(3-4). 349–358. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026